GovChime
IDVOther than small business

BPA (single-award IDV) HHSI236201200001BMCKESSON CORPORATION

Overview

Award facts

Obligated on orders under this IDV
$164.93M
$164,929,522 across 1,366 orders
Period of performance
From Aug 7, 2012
Modifications
10
Latest action Jul 25, 2024
Contract type
BPA (single-award IDV)
PIID HHSI236201200001B

Description of requirement

IHS-WIDE BLANKET PURCHASE AGREEMENT FOR OPEN MARKET PHARMACEUTICAL PRODUCTS NOT COVERED BY THE VETERANS ADMINISTRATION PHARMACEUTICAL PRIME VENDOR PROGRAM OR OTHER FEDERAL SUPPLY SCHEDULES

Dates and value

Award date
Signed on Aug 7, 2012
Ordering period ends
Oct 8, 2021
Ceiling
Ceiling (single-award vehicle): $500,000,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 25, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationSAN FRANCISCO, CA
UEIS1RUKWWRYFL6
CAGE code1MKG3
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMCKESSON CORPORATION

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Indian Health Service

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Set-aside
Not reported
Contract pricing
Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
Offers received
0

Contract details

Subcontracting plan
Plan not requiredB
Major program
Open market pharmaceuticals
Cost Accounting Standards clause
Not applicable exempt from CASX
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 7, 2012
Latest action
Jul 25, 2024 — Other administrative actionModification P00010; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action10
11 actions recorded, Aug 7, 2012 to Jul 25, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

A-76 (FAIR Act) action
No

Socio-economic and policy

Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
BPAE
Multiple or single award
Single awardS
Awarding agency code
7500
Awarding sub-tier code
7527
Contracting office code
75H711
Transactions recorded under this award key
11

Funding

Funding agency code
7500
Funding sub-tier code
7527
Funding office code
75H711